SteriLance Medical is pleased to announce its participation in Medlab Middle East 2025, held at the Dubai World Trade Centre. As the region’s leading medical laboratory exhibition and congress, the event brings together global experts committed to advancing patient-focused technologies.

At Booth Z1.B12, SteriLance Medical is highlighting its latest innovations in blood collection and diabetes care—products developed to support individuals who manage chronic conditions through regular self-monitoring and medication. From low-pain safety lancets to user-friendly insulin pen needles, these solutions are designed to enhance comfort, consistency, and confidence in daily health routines.

Medlab Middle East attracts over 20,000 attendees and features more than 800 exhibitors from 40+ countries. While the event covers a wide range of laboratory and diagnostic topics, SteriLance's presence reflects a growing focus on accessible care tools that extend beyond clinical settings and into the lives of patients.

Highlights of SteriLance Medical’s Participation:

• Personal Health Device Displays: Attendees can explore SteriLance's safety lancets and insulin delivery tools—purpose-built for diabetic users to support blood glucose monitoring and medication adherence at home and on the go.

• Collaborative Dialogue: The SteriLance team is on-site for discussions on how its devices are designed to integrate into real-life health management, with a focus on safety, reliability, and ease of use.

• Global Exchange: Medlab Middle East provides a valuable opportunity to connect with partners and stakeholders who share a vision for empowering patients through simple, effective technology.

SteriLance Medical welcomes all attendees to visit Booth Z1.B12 and explore how thoughtfully designed solutions can contribute to safer, more patient-centered care—especially for those living with diabetes.